Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

Osanetant - SR 142801

 

 

CAS 160492-56-8

C35H41Cl2N3O2  MW 606.64 

Purity: >98% (optically pure) 

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1533   Prime Source Promotion

 

Qty1: 5 mg (research sample) / 135  $176

 

Qty2: 25 mg (research sample) / 485  $631

 

Qty3: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for our product range and services.

Biological Activity:

 

Potent non-peptide neurokinin 3 (NK3) receptor antagonist. 

 

References: online

 

X Emonds-Alt et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci. 1995, 56(1), PL27-32.

 

F Kamali. Osanetant Sanofi-Synthélabo. Curr. Opin. Invest. Drugs. 2001, 2(7), 950-956.

 

L Quartara and M Altamura. Tachykinin receptors antagonists: from research to clinic. Curr. Drug Targets. 2006, 7(8), 975-992.

 

MA De Souza Silva et al. The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys. Eur. J. Pharmacol. 2006, 536(3), 269-278.

 

G Jocham et al. Neurokinin receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core. Eur. J. Neurosci. 2006, 24(6), 1721-1732.

 

 

Chemical Name: N-(1-{3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl]-N-methylacetamide

Osanetant - SR 142801 | NK3 antagonist | Axon Medchem | Axon 1533 | SR142801

axonmedchem.com © 2011

 

Axon Ligands In The Field:

 

Aprepitant | NK1 antagonist

Orvepitant | NK1 antagonist

TAK 637 | NK1 antagonist

 

GR 159897 | NK2 antagonist

Osanetant | NK3 antagonist

 

 

 

 

Axon Ligands TM

 

Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.